ESC Premium Access

GLP-1 Receptor agonists – Pioneers of further cardiovascular risk reduction in diabetes?

Event: ESC CONGRESS 2019
Topic: Risk Factors and Prevention
Session type: Satellite Symposium
Sponsored by Medscape through an independent educational grant from Novo Nordisk
Date: 31 August 2019
Time: 15:30 - 16:30

Session

6 presentations in this session

Diabetes and cardiovascular risk – Ugly twins

Speaker: Professor L. Leiter (Toronto, CA)
Thumbnail

Incretins and glucose homeostasis

Speaker: Doctor J. Meier (Bochum, DE)
Thumbnail

GLP-1 and the cardiovascular system

Speaker: Doctor M. Husain (Toronto, CA)
Thumbnail

Pioneering oral GLP-1 RAs in cardiovascular risk management

Speaker: Professor A. Consoli (Pescara, IT)
Thumbnail

Oral GLP-1 RA – a step change in cardiology?

Speaker: Professor L. Leiter (Toronto, CA)
Thumbnail

Panel discussion

Speaker: Professor L. Leiter (Toronto, CA)
Thumbnail

6 speakers from this session

Professor Lawrence Leiter

University of Toronto, Toronto (Canada)
18 presentations
0 follower

Doctor Juris Meier

, Bochum (Germany)
1 presentation
0 follower

Doctor Mansoor Husain

University of Toronto, Toronto (Canada)
7 presentations
1 follower

Professor Agostino Consoli

, Pescara (Italy)
1 presentation
0 follower

Professor Lawrence Leiter

University of Toronto, Toronto (Canada)
18 presentations
0 follower

Professor Lawrence Leiter

University of Toronto, Toronto (Canada)
18 presentations
0 follower

This platform is supported by

logo Novo Nordisk